Resistance to antimalarial drugs is one of the biggest problems currently facing malaria control. Recent studies looking at the genome of the malaria parasite could help scientists understand how drug resistance has evolved – and develop the tools needed to keep it in check.

In a small number of cases, doctors are able to use pharmacogenomics in their treatment of patients.

Pharmacogenomics is a specific kind of genetic testing that offers key advantages for doctors trying to choose the best drugs for their patients. 

Personal genomics is an area of genomics focusing specifically on the sequencing and analysis of one person’s genome, and then giving them their genomic information. 

An adverse drug reaction is when a medication given as instructed and at a normal dose has an unwanted or harmful effect on a patient.